Lexaria Bioscience Corp. (LXRP) Files Form 4 Insider Buying : Christopher Bunka Buys 59,000 Shares

Lexaria Bioscience Corp. (LXRP): Christopher Bunka , CEO of Lexaria Bioscience Corp. purchased 59,000 shares on Jul 6, 2016. The Insider buying transaction was reported by the company on Jul 7, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.11 per share for a total value of $5,485.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 24, 2016, John Martin Docherty (President) purchased 210,000 shares at $0.10 per share price.On Feb 17, 2016, Christopher Bunka (President) purchased 17,000 shares at $0.09 per share price.Also, On Nov 23, 2015, William Edward Mckechnie (director) purchased 100,000 shares at $0.19 per share price.

Leave a Reply

Lexaria Bioscience Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Lexaria Bioscience Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.